Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 43 Breast Neoplasms 29 Lymphoma 28 Sarcoma 26 Hodgkin Disease 24 Triple Negative Breast Neoplasms 20 Burkitt Lymphoma 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Follicular 17 Neoplasms 15 Ovarian Neoplasms 14 Lymphoma, Non-Hodgkin 13 Lymphoma, B-Cell 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, T-Cell, Peripheral 9 Endometrial Neoplasms 9 Neuroblastoma 7 Neoplasm Metastasis 7 Lymphoma, Mantle-Cell 7 Liposarcoma 7 Leukemia 7 Fallopian Tube Neoplasms 7 Recurrence 6 Multiple Myeloma 6 Leiomyosarcoma 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leukemia, Biphenotypic, Acute 5 Inflammatory Breast Neoplasms 5

Interventions

nirogacestat 5 Specimen Handling 3 Cryosurgery 3 X-Rays 2 Phantoms, Imaging 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Blood Specimen Collection 2 trifluridine tipiracil drug combination 1 Oxaliplatin 1 Leucovorin 1 Ipilimumab 1 Imatinib Mesylate 1 High-Intensity Focused Ultrasound Ablation 1 Fluorouracil 1 Embolization, Therapeutic 1 Electrochemotherapy 1 E-7386 1 Doxorubicin 1 Cyclophosphamide 1 Cryotherapy 1 CTLA-4 Antigen 1 Bone Density 1 Bleomycin 1 Biopsy 1 Bevacizumab 1 Absorptiometry, Photon 1 4-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Desmoid Tumors × Doxorubicin × 1 year × Clear all

NCT06268457 2026-05-14

Embodesmo

Istituto Ortopedico Rizzoli

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡